Torrent Pharmaceuticals gets observations from USFDA for Dahej plant

08 Apr 2019 Evaluate

Torrent Pharmaceuticals has received certain observations from the US Food and Drug Administration (USFDA) for Dahej plant which are procedural in nature and the company is confident of addressing them satisfactorily. The audit at Dahej Plant of the company was carried out by USFDA in the month of March, 2019.

Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharma Share Price

3742.90 -14.55 (-0.39%)
17-Dec-2025 09:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.45
Dr. Reddys Lab 1273.40
Cipla 1498.50
Zydus Lifesciences 920.00
Lupin 2118.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×